GH(Guardant Health, Inc.) · 财务报表

GH(Guardant Health, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$373.65M$449.54M$563.95M$739.02M$982.02M
毛利润——$336.90M$449.22M$633.01M
营业利润−$411.00M−$544.38M−$564.73M−$443.59M−$437.25M
净利润−$384.77M−$654.59M−$479.45M−$436.37M−$416.28M
经营现金流−$209.02M−$309.46M−$324.98M−$239.86M−$184.76M
自由现金流−$284.05M−$386.92M−$345.46M−$274.94M−$233.07M
摊薄每股收益$-4.00$-6.41$-4.28$-3.56$-3.32

Guardant Health, Inc. GH